VBI Vaccines
VBIV
#10526
Rank
HK$14.63 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.25%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$79.22. In 2022 the company made an earnings per share (EPS) of -HK$103.13 a decrease over its 2021 EPS that were of -HK$63.29.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$103.1362.96%
2021-HK$63.2928.57%
2020-HK$49.22-54.35%
2019-HK$107.82-52.58%
2018-HK$227.3610.23%
2017-HK$206.2614.29%
2016-HK$180.48-62.8%
2015-HK$485.1990.68%
2014-HK$254.46-7.95%
2013-HK$276.45-57.97%
2012-HK$657.80-78%
2011-HK$2,9903151.47%
2010-HK$91.9723.87%
2009-HK$74.25-18.48%
2008-HK$91.0912.08%
2007-HK$81.27-49.47%
2006-HK$160.85
2005N/A-100%
2004-HK$71.5011.94%
2003-HK$63.88-81.89%
2002-HK$352.71196.44%
2001-HK$118.9884.33%
2000-HK$64.55-65.37%
1999-HK$186.40-29.45%
1998-HK$264.2029.61%
1997-HK$203.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.42-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.67-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.83-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA